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two classes of introns (reviewed in Reed, 2000; Moore,
2000). The AG-dependent introns typically contain weak
PY tracts and fail to undergo the first step of splicing
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when the AG is mutated. In contrast, AG-independentUniversity of Connecticut Health Center
introns contain strong PY tracts. When the AG of AG-263 Farmington Avenue
independent introns is mutated, the first step of splicingFarmington, Connecticut 06030
still occurs, but the second step fails to take place. Thus,
the 3 splice site AG is an important element for both
spliceosome assembly and 3 splice site selection.Alternative splicing is an important means of regulat-
The PY tract is recognized by the 65 kDa subunit ofing the expression of eukaryotic genes and enhancing
U2AF (U2AF65), which in turn interacts with and recruitsprotein diversity. A detailed examination of the Dro-
U2 snRNP to the BPS (Reed, 2000; Moore, 2000) (Figuresophila Sex-lethal gene has led to two significant dis-
2A). The U2AF heterodimer also contains a 35 kDa sub-coveries—the role of the splicing factor SPF45 in defin-
unit (U2AF35) that physically contacts the AG dinucleo-ing the site of exon ligation, and that alternative
tide (Wu et al., 1999; Zorio and Blumenthal, 1999; Meren-splicing can be regulated at the second step.
dino et al., 1999). However, several lines of evidence
suggest that the U2AF35-AG interaction is not essentialAlternative splicing of eukaryotic pre-messenger RNAs
for determining the actual site of exon ligation. First, in(pre-mRNAs) is a powerful means of regulating gene
a bimolecular splicing system, spliceosomes that haveexpression and enhancing proteome diversity (Black,
already carried out the first step of splicing on a 52000). In all cases examined so far, the regulation of
half RNA lacking the AG and downstream exon canalternative splicing is achieved by controlling the initial
accurately ligate exon 1 to a second RNA containing anbinding of general splicing factors to the splice site(s)
AG and exon 2 (Anderson and Moore, 1997). Since U2AFflanking the regulated exon (Smith and Valca´rcel, 2000).
is thought to dissociate from the spliceosome prior toIn a recent issue of Cell, Valca´rcel, Lamond, and cowork-
the first step of splicing (Bennett et al., 1992), it is unlikelyers discuss their discovery of a radically different splic-
that U2AF35 is responsible for selecting the AG used foring regulatory mechanism—the inhibition of splicing
the second step. Secondly, accurate splicing can occurafter intron removal has begun (Lallena et al., 2002). This
for AG-independent pre-mRNAs in the absence offinding extends the regulatory repertoire of the splicing
U2AF35 (Zamore et al., 1992). However, AG selection ismachinery and highlights how much remains to be un-
an essential process—pre-mRNAs lacking an AG in thederstood about the splicing reaction in general.
vicinity of the BPS stall after the first step. Thus, the AGThe Splicing Reaction and Spliceosome Assembly
is recognized at least twice during the splicing reac-Introns are excised from pre-mRNAs by two consecutive
tion—early during spliceosome assembly and prior totransesterification reactions (Burge et al., 1999) (Figure
exon ligation.1) that are likely to be catalyzed by the RNA components
It has been proposed that a scanning mechanism mayof the spliceosome (Villa et al., 2002). At the core of
exist that functions to select the first AG downstreamthe spliceosome are 5 small nuclear ribonucleoprotein
of the BPS (Anderson and Moore, 1997). However, thisparticles (snRNPs) that are involved in specific interac-
mechanism cannot explain several examples where the
tions with the pre-mRNA. In addition to the snRNPs, the
AG closest to the BPS is not used (reviewed in Reed,
spliceosome contains a multitude of accessory proteins
2000; Moore, 2000). In addition to scanning, the protein
that carry out a variety of tasks. The spliceosome is Slu7 appears to play an important role in selecting the
thought to assemble onto the pre-mRNA in a step-wise correct AG for exon ligation (Chua and Reed, 1999).
manner. The initial step of spliceosome assembly in- When Slu7 is depleted from nuclear extracts, aberrant
volves the recognition of the 5 splice site by U1 snRNP, AGs are selected for exon ligation. However, the precise
the branchpoint sequence (BPS) by Branchpoint Bind- mechanism by which Slu7 participates in AG selection
ing Protein/Splicing Factor 1 (BBP/SF1) and the pyrimi- has not yet been determined, and it may act indirectly.
dine (PY) tract near the 3 splice site by the heterodimeric The results of Lallena et al. reported in the recent issue
splicing factor U2 auxiliary factor (U2AF). Subsequently, of Cell identify a new protein involved in AG selection.
U2AF recruits U2 snRNP to the BPS, BBP/SF1 and U2AF SPF45—A Novel Protein Involved in AG Selection
dissociate from the spliceosome, and the U4, U5, and Last year, the same group reported that the presence
U6 snRNPs are incorporated into the spliceosome. At of two different AGs at the 3 splice site of exon 3 is
this point, a massive conformational rearrangement oc- important for alternative splicing of the Drosophila Sex-
curs to form the catalytically active spliceosome and lethal (Sxl) pre-mRNA (Penalva et al., 2001). The two
the first step of splicing ensues. AGs are located 16 nucleotides apart and are separated
3 Splice Site Recognition and Selection by a pyrimidine-rich sequence. The upstream AG is the
Nearly all metazoan introns contain an AG dinucleotide normal site of exon ligation, while the downstream AG
just upstream of the phosphodiester bond that serves is required for the recognition of exon 3—mutation of the
as the site of exon ligation. In vitro studies have identified downstream AG leads to exon skipping. In the current
study, Lallena et al. have extended these experiments
by identifying the splicing factors responsible for recog-1Correspondence: graveley@neuron.uchc.edu
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can be complemented by expression of human SPF45
in S2 cells treated with dSPF45 dsRNA. Thus, SPF45 is
directly involved in selecting the AG that is used for the
site of exon ligation in vitro and in vivo.
SXL, SPF45, and Second Step Splicing Regulation
The finding that SPF45 is involved in selection of the
AG for the second step of splicing is significant in its
own right. However, Lallena et al. go on to show that
SXL can regulate alternative splicing at the second step
by targeting the activity of SPF45. To appreciate the
significance of this result, it is important to stress that
all known splicing regulatory mechanisms act at the
earliest stages of spliceosome assembly (Smith and
Valca´rcel, 2000).
The alternative splicing cascade that controls Dro-
sophila sex determination is one of the most elegant
regulatory pathways known in nature and has provided
many examples of how alternative splicing is regulated
(Lopez, 1998). SXL is an extraordinarily versatile protein
that regulates the alternative splicing of at least threeFigure 1. The Chemical Mechanism of the pre-mRNA Splicing Re-
pre-mRNAs (Sxl, transformer (tra), and male-specific le-action
thal-2 (msl-2)), and regulates translation of at least oneIn the first step of splicing, the 2OH of an intronic adenosine located
mRNA, msl-2. One of the most important functions ofwithin an element known as the branchpoint sequence (BPS) attacks
SXL is regulating the splicing of its own pre-mRNA (Fig-the phosphodiester bond at the 5 splice site to generate a free
exon 1 and intron-exon 2 intermediates. At this point, the intron is ure 3). In males, exon 3, which contains an in frame stop
in the form of a lariat containing a 2–5 bond between the 5 end codon, is always included in the Sxl pre-mRNA and no
of the intron and the BPS adenosine. In the second step of the functional SXL protein is produced. However, in females,
reaction, the free 3 OH of exon 1 attacks the phosphodiester bond
SXL represses exon 3 inclusion, creating a feedbackat the 3 splice site to yield the ligated exons and lariat intron.
loop that ensures that the expression of SXL is main-
tained. SXL also represses the utilization of male-spe-
cific 3 splice sites in both the msl-2 and tra pre-mRNAsnizing each of these AGs. Their findings are rather sur-
(Figure 3), which encode proteins involved in dosageprising. First, U2AF actually binds to the exonic PY tract
compensation and regulating the alternative splicing ofand downstream AG (Figure 2). This result demonstrates
two other sex determination genes, respectively. SXLfor the first time that U2AF can carry out its normal
regulates the splicing of the msl-2 and tra pre-mRNAsfunction when bound to an exon. Moreover, since the
at the earliest stage of spliceosome assembly by binding
AG selected for exon ligation is different than the AG
to the PY tract upstream of the regulated exon and
recognized by U2AF35, what is responsible for selecting
interfering with U2AF binding.
the AG for the second step of splicing?
The results of Lallena et al. add a significant new
Using a site-specifically labeled RNA probe, the splic- twist to the possible mechanisms by which alternative
ing factor SPF45 was shown to interact directly with the splicing can be regulated. The Sxl pre-mRNA contains
AG that is used for exon ligation (Figure 2). SPF45 was multiple SXL binding sites both upstream and down-
initially identified by mass spectrometry by the Lamond stream of the regulated 3 splice site. The binding of
lab as a protein of unknown function contained within SXL near the 3 splice site of Sxl exon 3, in a pre-mRNA
the purified human spliceosome (Neubauer et al., 1998). containing only two exons, stalls the splicing reaction
Interestingly, SPF45 contains an RNA recognition motif after the first step in vitro. However, when the upstream
(RRM) in its C terminus that is most closely related to the AG is mutated, eliminating the binding of SPF45 to the
RRM of U2AF35. Consistent with their previous findings pre-mRNA, SXL still binds to the RNA, but is no longer
(Penalva et al., 2001), Lallena et al. show that recognition able to inhibit the second step of splicing. The expres-
of the downstream AG by U2AF35 is required for the sion of SXL in S2 cells causes Sxl exon 3 skipping
interaction of SPF45 with the upstream AG. Thus, either whereas depletion of dSPF45 by RNAi impairs the ability
U2AF and SPF45 cooperatively bind to the RNA, or U2AF of SXL to repress exon 3 splicing. Thus, in order for SXL
directly or indirectly recruits a splicing factor that is to regulate Sxl alternative splicing, SPF45 must interact
required for SPF45 binding. with the upstream AG.
Two lines of evidence strongly suggest that SPF45 Lallena et al. also find that SXL and SPF45 physically
not only binds to the AG, but that it actively participates interact with one another via their amino termini. This
in AG selection during the second step. First, when interaction is critical for the ability of SXL to regulate
SPF45 is immunodepleted from nuclear extracts, the splicing since a variant of SXL lacking the SPF45 interac-
upstream AG is not used for exon ligation. Instead, the tion domain that binds RNA is unable to inhibit splicing
downstream AG is now selected as the site of exon to the SPF45 recognized AG. This is consistent with
ligation (Figure 2A). Second, the same result is obtained previous experiments demonstrating that the N-terminal
in cultured Drosophila S2 cells when Drosophila SPF45 region of SXL is required for the autoregulation of Sxl
(dSPF45) is depleted with SPF45 dsRNA, which acti- alternative splicing in Drosophila cells (Wang and Bell,
2002). Likewise, one would predict that specific allelesvates the RNA interference (RNAi) pathway. This effect
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Figure 2. Regulating Alternative Splicing at
the Second Step in the Sxl pre-mRNA
(A) 3 splice site recognition in the absence
of SXL. U2AF bound to the PY tract and AG
within exon 3 recruits U2 snRNP to the BPS.
After the first step of splicing, the AG recog-
nized by the splicing factor SPF45 is used as
the site of exon ligation. In the absence of
SPF45, the downstream AG that was initially
recognized by U2AF is used as the site of
exon ligation.
(B) The mechanism of SXL autoregulation.
When the splicing regulator SXL is present, it
binds to the pre-mRNA, interacts with SPF45,
and blocks both exon 3 AGs from being uti-
lized as the site of exon ligation. Instead, exon
2 is ligated to exon 4.
of SPF45 that are unable to interact with SXL should been recognized by the splicing machinery. What has
evolved is a rather complex mechanism involving SXL,display a sex transformation phenotype since female
flies would be expected to utilize the downstream AG SPF45, and an intricately organized 3 splice site con-
taining two functional AGs. Although this is the firstand therefore include exon 3. Biochemical experiments
revealed that the binding of SXL to the pre-mRNA does example of splicing regulation at the second step, it
is possible that other pre-mRNAs for which alternativenot displace SPF45. Together, these results lead to a
model in which the binding of U2AF to exon 3 results splicing must be controlled with a precision equal to
that of Sxl will be regulated in a similar manner.in the recruitment of U2 snRNP to the upstream BPS
and this, either directly or indirectly, results in binding SPF45 and Human Disease
Of course, one must wonder how widespread this regu-of SPF45 to the upstream AG (Figure 2). After the first
step of splicing has occurred, the AG recognized by latory mechanism is. To extend their findings from Dro-
sophila to humans, Lallena et al. reexamined an earlierSPF45 is utilized as the site of exon ligation (Figure 2).
However, if SXL is present, it interacts with SPF45 and finding made by Maniatis, Weiner, and their colleagues
(Krainer et al., 1985; Zhuang and Weiner, 1990) regardingsomehow prevents the ability of the spliceosome to uti-
lize either AG at the 3 splice site of exon 3 (Figure 2B).
Instead, exon 2 is ligated to the 3 splice site of exon 4.
Sex and the Second Step
Why should alternative splicing be regulated at the sec-
ond step? At first glance, intuition suggests that the
best way to prevent an exon from being included in
the mRNA would be to block its initial recognition. In
addition, regulating splicing at the second step has the
potential to be energetically demanding if the stalled
spliceosome is not able to identify a new 3 splice site
to use for exon ligation. However, in the case of Sxl,
regulating splicing at the second step actually makes
sense.
Usually, the splice sites flanking alternatively spliced
exons are suboptimal, and bind weakly to their respec-
tive splicing factors (Smith and Valca´rcel, 2000). As a
result, it is fairly easy for splicing regulators to positively
or negatively affect binding of the splicing machinery to
the splice sites. In addition, in most cases, it appears
that splicing regulation does not need to occur with very
high fidelity. However, in the case of Sxl, pre-mRNA
splicing must be regulated absolutely precisely since
the production of even trace amounts of SXL protein in Figure 3. The Drosophila Sex Determination Alternative Splicing
Cascademales could result in a sexual transformation. Thus, it
is essential that exon 3 is always included in males The Sex-lethal (Sxl) pre-mRNA (only exons 2, 3, and 4 are shown)
is alternatively spliced in males in females. In females, exon 3 is(Figure 3). This requires that the splicing machinery have
skipped and SXL protein is produced, which autoregulates the splic-a high affinity for the exon 3 splice sites. Consequently,
ing of Sxl pre-mRNA, and represses the male-specific splice sites init may be difficult for SXL to interfere with the initial
the transformer (tra) and male-specific lethal-2 (msl-2) pre-mRNAs.
binding of the splicing machinery to the splice sites Female-specific splicing of tra results in the synthesis of TRA protein
flanking exon 3. Thus, SXL must act through a different that positively regulates alternative splicing of the doublesex (dsx)
and fruitless (fru) pre-mRNAs.mechanism that represses splicing after exon 3 has
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a specific mutation in the human -globin gene, 110, function, plays such a pivotal role in defining the site
that causes -thalassemia. The 110 allele contains a of exon ligation, the regulation of sex-determination in
single base mutation in the first intron that creates a Drosophila, and the activation of cryptic splice sites that
new AG dinucleotide between the BPS and the normal cause human disease, underscores how much we have
3 splice site AG. This mutation results in the utilization to learn about the general workings of the spliceosome.
of the new upstream AG as the site of exon ligation rather
Selected Readingthan the normal downstream AG. Intriguingly, when the
downstream AG is mutated, exon 2 is skipped entirely
Anderson, K., and Moore, M.J. (1997). Science 276, 1712–1716.
and exon 1 is ligated directly to exon 3 (Krainer et al.,
Bennett, M., Michaud, S., Kingston, J., and Reed, R. (1992). Genes1985). This is the very same phenotype observed for the
Dev. 6, 1986–2000.
Sxl pre-mRNA when the downstream AG is mutated.
Black, D.L. (2000). Cell 103, 367–370.
Lallena et al. tested whether SPF45 might be involved
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P., Sleeman, J., Lamond, A., and Mann, M. (1998). Nat. Genet. 20,specify that the correct AG, and not the one originally
46–50.recognized by U2AF35, is to be used for exon ligation?
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exon 2 becomes joined to exon 4. Does the 3 OH of
exon 2 directly attack the 3 splice site of exon 4 without
the intron between exons 3 and 4 undergoing the first
step of splicing? If so, how is the 3 splice site of exon
4 chosen as the site of exon ligation? Alternatively, if
the intron between exons 3 and 4 does undergo the first
step of splicing, what prevents the 5 splice site of exon
3 from being ligated to exon 4? Does SXL also interfere
with the ability of the 5 splice site of exon 3 to participate
in exon ligation? Clearly, many details of Sxl regulation
remain to be worked out.
The genome sequences of model organisms have led
to a newfound appreciation for the frequency and impor-
tance of alternative splicing in regulating gene expres-
sion and generating protein diversity (Black, 2000).
Given the tremendous number of alternative splicing
events that take place, it is expected that splicing can
be regulated by a variety of means. To date, however,
relatively few splicing regulatory mechanisms are known.
The finding that alternative splicing can be regulated
at the second step adds a new item to the regulatory
repertoire of the spliceosome. In addition, the finding
that SPF45, a splicing factor of previously unknown
